Expanding the Therapeutic Frontier in Atherosclerosis

Journal of Cardiovascular Pharmacology - United States
doi 10.1097/fjc.0b013e3182a18bea
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Inflammation as a Therapeutic Target in Atherosclerosis

Journal of Clinical Medicine
2019English

Small-Angle Scattering for Structural Biology-Expanding the Frontier While Avoiding the Pitfalls

Protein Science
BiochemistryMedicineMolecular Biology
2010English

Resolution of Inflammation: A New Therapeutic Frontier

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2016English

Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Liver X Receptors as Potential Therapeutic Targets in Atherosclerosis

Clinical and Investigative Medicine
Medicine
2009English

FXR an Emerging Therapeutic Target for the Treatment of Atherosclerosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Key Recent Advances in Atherosclerosis Treatment With Modern Lipid-Lowering Drugs: The New Frontier With PCSK9 Inhibitors

European Cardiology Review
Cardiovascular MedicineCardiology
2017English

Therapeutic Potential of Phosphoethanolamine-Bound C-Reactive Protein in Atherosclerosis

Future Lipidology
2008English

Cytotoxic Lymphocytes and Atherosclerosis: Significance, Mechanisms and Therapeutic Challenges

British Journal of Pharmacology
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy